All stock lists
Corcept Therapeutics Inc (CORT)
United States · Delayed Price · Currency is USD
Pharmaceutical Preparations
87.59+1.73 (+2.01%)
Insider Score
––Not scored
CORT Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CORT analyst forecast
CORT analyst consensus
No analyst ratings in the last 3 months.
CORT 12-month price target
$143.50+64.1% upsideaverage of 4 firms
$165.00High
$95.00Low
Best analysts covering CORT
No firm covering CORT has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CORT analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Truist Financial | — | $164.00 | +40.0% | — | 2026-08-18 | |
| H.C. Wainwright | — | $165.00 | +77.5% | — | 2026-07-30 | |
| Canaccord Genuity | — | $150.00 | +59.3% | — | 2026-07-29 | |
| H.C. Wainwright | — | $95.00 | +34.9% | — | 2026-06-02 | |
| H.C. Wainwright | — | $105.00 | +153.2% | — | 2026-01-22 | |
| H.C. Wainwright | — | $90.00 | +147.6% | — | 2026-01-02 | |
| Canaccord Genuity | — | $99.00 | +168.3% | — | 2026-01-02 | |
| UBS | — | $95.00 | +8.8% | — | 2025-12-16 | |
| Truist Financial | — | $135.00 | +90.8% | — | 2025-05-06 | |
| H.C. Wainwright | — | $145.00 | +96.1% | — | 2025-05-06 | |
| H.C. Wainwright | — | $80.00 | +69.6% | — | 2024-10-18 | |
| Truist Financial | — | $76.00 | +73.0% | — | 2024-09-30 | |
| Canaccord Genuity | — | $78.00 | +124.7% | — | 2024-08-15 | |
| Piper Sandler | — | $38.00 | +5.2% | — | 2024-07-30 | |
| H.C. Wainwright | — | $45.00 | +23.2% | — | 2024-07-30 | |
| Canaccord Genuity | — | $38.00 | +15.9% | — | 2024-06-12 | |
| Piper Sandler | — | $35.00 | +11.1% | — | 2024-06-10 | |
| Truist Financial | — | $65.00 | +105.8% | — | 2024-06-04 | |
| H.C. Wainwright | — | $40.00 | +67.5% | — | 2024-05-02 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.